Steward Financial Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3K | Buy |
+32
| New | +$3K | ﹤0.01% | 860 |
|
|
2023
Q2 | – | Sell |
-19
| Closed | -$1K | – | 798 |
|
|
2023
Q1 | $1K | Buy |
19
+5
| +36% | +$263 | ﹤0.01% | 635 |
|
|
2022
Q4 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 441 |
|
|
2022
Q3 | – | Sell |
-11
| Closed | -$1K | – | 872 |
|
|
2022
Q2 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 806 |
|